NLRP3 and primary biliary cholangitis: We conclude that there is a correlation among NLRP3 inflammasome activation in the liver-gut axis, liver injury, and intestinal barrier disruption in PBC and PSC, which may be closely related to the susceptibility of patients with PBC or PSC to inflammatory bowel disease.